TP53 and PTEN alterations appeared to contribute similarly to the lower tumor suppressor alteration frequency in non-Hispanic Black veterans, while MMR deficiency and CDK12 alterations appeared to contribute similarly to the increase in immunotherapy targets in non-Hispanic Black individuals (Figure 1B). The gene discussed is CDK12; the disease is mismatch repair cancer syndrome 1.